EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Alternaria Allergy and Immunotherapy

Hao Chen, Rongfei Zhu

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000539237 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Hao Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, chenhao1019@126.com. Hauptthemen laut MEDLINE: Alternaria, Desensitization, Immunologic, Allergens, Hypersensitivity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Allergen immunotherapy (AIT) is the only known causative treatment for Alternaria allergy, but the difficulty in standardizing Alternaria extracts hampers its effectiveness and safety. Summary: Alternaria, a potent airborne allergen, has a high sensitization rate and is known to trigger the onset and exacerbation of respiratory allergies, even inducing fungal food allergy syndrome in some cases. It can trigger a type 2 inflammatory response, leading to an increase in the secretion of type 2 inflammatory cytokines and eosinophils, which are the culprits behind allergic symptoms. Diagnosing Alternaria allergy is a multistep process, involving a careful examination of clinical symptoms, medical history, skin prick tests, serum-specific IgE detection, or provocation tests. Alt a1, the major component of Alternaria, is a vital player in diagnosing Alternaria allergy through component-resolved diagnosis. Interestingly, Alternaria can reduce the protein activity of other allergens like pollen and cat dander when mixed with them. In order to solve the problems of standardization, efficacy and safety of traditional Alternaria AIT, novel AIT methods targeting Alt a1 and innovative vaccines such as epitope, DNA, and mRNA vaccines seem promising in bypassing the standardization issue of Alternaria extracts. But these studies are in early stages, and most researches are still focused on animal models, calling for more evidence to validate their use in humans. Key Messages: This review delves into the various aspects of Alternaria allergy, including characteristics, epidemiology, immune mechanisms, diagnosis, clinical manifestations, and the application and limitations of Alternaria AIT, aiming to provide a foundation for the management of patients with Alternaria allergy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlternariaDesensitization, ImmunologicAllergensHypersensitivityHumansAnimalsAntigens, Fungal

Stichwörter der Autor:innen

Allergen componentAllergen immunotherapyAlternariaStandardizationVaccines

Substanzen

AllergensAntigens, Fungal

Autor:innen und Institutionen

  • Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, chenhao1019@126.com.
  • Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Institute of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zitieren

APA

Chen, H., & Zhu, R. (2024). Alternaria Allergy and Immunotherapy. International Archives of Allergy and Immunology. https://doi.org/10.1159/000539237

Vancouver

Chen H, Zhu R. Alternaria Allergy and Immunotherapy. International Archives of Allergy and Immunology. 2024. doi:10.1159/000539237

BibTeX
@article{Chen2024,
  author = {Chen, Hao and Zhu, Rongfei},
  title = {Alternaria Allergy and Immunotherapy},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000539237}
}
Kostenlos starten →